13012021_Galderma_DS_03_0456(720x740).jpg
About us

AT A GLANCE

With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.
We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine.
Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.

KEY FACTS ABOUT GALDERMA

~3B USD

audited 2020 net sales

~4,600

employees in 100 countries

4

manufacturing sites

1,200+

employees work at our 4 manufacturing sites. We make 75% of our products in house. 

3

Global Business Units: Aesthetics, Consumer Care and Prescription Medicine

World presence

we operate from 50 sites in 40 countries, with our headquarters in Switzerland.

A timeline of our history

1981
Foundation of Galderma as a joint venture between L’Oréal and Nestlé

Following the invention of the first Cetaphil formulation in 1947

1984
Galderma discovers Adapalene

1986
First commercial operations

1995
Launch of Differin for acne treatment

2000
Opening of our production site in Baie d’Urfé, Canada

2001
Licensing agreement for Metvix (Skin cancer)

2004
Opening of our production site in Hortolândia, Brazil

2007
Launch of Differin 0.3%

2008
Launch of Epiduo

2009
Launch of Azzalure and Restylane Injector

 

 

2011
Acquisition of Q-med, maker of Restylane

2014
Nestlé Skin Health is founded – Galderma becomes a wholly-owned subsidiary of Nestlé

2016
Acquistion of The Proactiv Company

2019
Galderma debuts as the world’s largest independent global dermatology company following acquisition by a consortium of institutional investors